3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer - Cervical cancer -

Only 1 in 5 women in developing world receive effective cervical cancer screening

Cancer • • Cervical cancerJun 17, 08

Few women in the developing world are screened effectively for cervical cancer and those at highest risk of developing the disease are among the least likely to be screened, accordingly an analysis published in PLoS Medicine. The study, by Emmanuela Gakidou (University of Washington, Seattle, USA) and colleagues, also finds striking inequalities in access to cervical cancer screening between and within countries.

Cervical cancer is the second-most common cancer in women and a leading cause of death worldwide. Since the 1970s, the developed world has seen a fall in the annual number of new cases of cervical cancer, and a fall in the death rate from the disease. This public health success is often credited to widespread screening programmes. But in the developing world, where most cervical cancer occurs, there is little information about rates of screening.

To address this lack of information and to estimate the magnitude of inequalities in access to screening services, Gakidou and colleagues analyzed World Health Organization surveys from 57 countries across all levels of economic development.

They calculated the results both in terms of effective coverage (the proportion of eligible women who had had a pelvic exam and a Pap smear test in the last three years) and crude coverage (the proportion of eligible women who reported they had just had a pelvic exam, regardless of when this occurred). By both measures the researchers found a huge disparity in rates of cervical cancer screening; in terms of effective coverage only 19% of women in the developing world have been screened compared to 63% in developed countries.

The findings also show a wide gap between those countries with the most effective cervical cancer screening programmes and those where little screening for cervical cancer takes place at all. For example, over 80% of women receive effective screening in Austria compared to 1% or less in Ethiopia and Bangladesh. In 16 of the 57 countries studied, most women have never had a pelvic exam and in Ethiopia, Malawi and Bangladesh, this is true of 90% of women.

The researchers found that poor women, who are likely to have higher exposure to cervical cancer risk factors such as smoking or unsafe sex, are less likely to get screened effectively. In developing countries as a whole, screening coverage rates also decline with advancing age, which is when cervical cancer incidence rates are known to be highest.

“Strategies for improving cervical cancer prevention must be adapted to meet the specific needs of individual countries,” conclude the authors. “Expanded screening may be a viable option where sufficient infrastructure and health system access exists, but novel strategies need to be considered in other settings.”

###

Citation: Gakidou E, Nordhagen S, Obermeyer Z (2008) Coverage of cervical cancer screening in 57 countries: Low average levels and large inequalities. PLoS Med 5(6): e132.

CONTACT:
Emmanuela Gakidou
University of Washington
Institute for Health Metrics and Evaluation
Seattle, WA 98121
United States of America
+1 206 897 2810
.(JavaScript must be enabled to view this email address)


Contact: Andrew Hyde
.(JavaScript must be enabled to view this email address)
01-223-463-330
Public Library of Science



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site